STOCK TITAN

EPS restatement leaves U.S. Global (NASDAQ: GROW) results unchanged

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
8-K

Rhea-AI Filing Summary

U.S. Global Investors, Inc. is restating its earnings per share (EPS) for the quarter and nine months ended March 31, 2026, and has advised that prior financial statements for these periods should no longer be relied upon. The company found a spreadsheet formula omission that understated weighted-average shares by 702,484 for the quarter and 230,743 for the nine months, causing basic and diluted EPS to be overstated by $0.02 and $0.01, respectively. The corrected basic and diluted EPS for the quarter is $0.21, with restated weighted-average shares of 12,561,208 basic and 12,585,586 diluted. The error does not affect revenue, expenses, net income, cash flows, or period-end shares, but management concluded a material weakness existed in internal control over financial reporting related to review of the share-count calculation and is implementing enhanced spreadsheet and review controls. The company highlights that net income for the quarter was $2.7 million and average assets under management reached $1.6 billion, and notes it has repurchased about 2.7 million shares over five years, more than 20% of its common stock.

Positive

  • None.

Negative

  • Material weakness in controls: Management concluded a material weakness existed in internal control over financial reporting related to review of the weighted-average shares calculation, raising concerns about past and future reporting accuracy.
  • Non-reliance and EPS restatement: The company’s prior financial statements and related communications for the March 31, 2026 periods should no longer be relied upon, and EPS will be restated after a spreadsheet error overstated per-share results.

Insights

Small EPS restatement, but a disclosed control weakness makes this a cautious event.

The company is restating EPS because a spreadsheet formula omitted part of the share count, overstating basic and diluted EPS by $0.02 for the quarter and $0.01 for the nine months. Core financials such as revenue, net income, and cash flow are unchanged.

Management determined there was a material weakness in internal control over financial reporting tied to review of the weighted-average share calculation. A material weakness signals that similar errors could occur if controls are not improved, even if this specific misstatement is modest in size.

They plan to file an amended Form 10‑Q/A and to enhance review procedures and spreadsheet controls. The company also underscores quarterly net income of $2.7 million and average assets under management of $1.6 billion, along with a multi‑year buyback that retired about 2.7 million shares, to frame the restatement against otherwise solid operating metrics.

Item 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report Governance
Previously issued financial statements should no longer be relied upon due to errors or restatements.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Quarter EPS correction $0.21 EPS Corrected basic and diluted EPS for quarter ended March 31, 2026
EPS overstatement (quarter) $0.02 per share Prior overstatement of basic and diluted EPS for the three months ended March 31, 2026
Quarter net income $2.7 million Net income for the quarter ended March 31, 2026
Average AUM $1.6 billion Average assets under management for the quarter ended March 31, 2026
Understated weighted-average shares (quarter) 702,484 shares Shortfall in basic and diluted weighted-average shares for three months ended March 31, 2026
Share repurchases 5 years 2.7 million shares Common stock repurchased over five years ended March 31, 2026, more than 20% reduction
Share price range $2.55–$2.71 GROW trading range May 13, 2026 through May 29, 2026
Average daily volume 24,154 shares Average daily trading volume May 13, 2026 through May 29, 2026
Non-Reliance on Previously Issued Financial Statements regulatory
"concluded that the Company’s previously issued consolidated financial statements ... should no longer be relied upon"
earnings per share (EPS) financial
"used to compute basic and diluted earnings per share (“EPS”)"
Earnings per share (EPS) is the portion of a company’s net profit allocated to each outstanding share of common stock, calculated by dividing profit after expenses by the number of shares. Investors use EPS to gauge how much profit each share represents — like measuring how big a slice of a pie each shareholder gets — and compare profitability across companies or over time; higher or rising EPS often supports stronger stock valuations while falling EPS can signal concern.
weighted average shares outstanding financial
"miscalculation of basic and diluted weighted average shares outstanding used to determine basic and diluted EPS"
The weighted average shares outstanding is the average number of a company’s common shares that were available during a reporting period, adjusted so each change (like new shares issued or shares bought back) counts only for the portion of the period it was in effect. Investors use it to calculate per-share measures such as earnings per share, so it shows how ownership dilution or buybacks affect what each share is entitled to—like averaging how many people were at a potluck over time to determine each person’s share of the food.
material weakness regulatory
"has concluded that a material weakness existed in internal control over financial reporting"
A material weakness is a significant flaw in the systems and checks a company uses to ensure its financial reports are accurate, meaning errors or fraud could happen and not be caught. For investors it matters because it raises the risk that reported results are unreliable—similar to finding a hole in a ship’s hull—potentially leading to corrected financials, regulatory action, reduced trust, and negative effects on stock value and borrowing costs.
internal control over financial reporting regulatory
"material weakness existed in internal control over financial reporting as of March 31, 2026"
Internal control over financial reporting is a company’s system of procedures and checks designed to make sure its financial statements are accurate and complete, like a set of guardrails and verification steps that catch mistakes or fraud before numbers are published. Investors care because strong controls make reported results more trustworthy, lower the risk of surprise restatements or regulatory problems, and give greater confidence when valuing the company or comparing it to peers.
share repurchase program financial
"ongoing share repurchase program is longstanding"
A share repurchase program is when a company buys back its own shares from the marketplace. This reduces the total number of shares available, which can increase the value of each remaining share and signal confidence in the company's prospects. For investors, it often suggests that the company believes its stock is undervalued or that it has extra cash to return to shareholders.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0000754811 0000754811 2026-05-29 2026-05-29
 


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
FORM 8-K
 

 
CURRENT REPORT     
 
Pursuant to Section 13 Or 15(d) Of
The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): May 29, 2026
 
 
U.S. GLOBAL INVESTORS, INC.
(Exact name of registrant as specified in its charter)
 
Texas
0-13928
74-1598370
(State of other jurisdiction of incorporation) 
(Commission File Number)
(IRS Employer Identification No.)
 
7900 Callaghan Road, San Antonio, Texas 78229
(Address of principal executive offices)  (Zip Code)
 
Registrant's telephone number, including area code: 210-308-1234
 

(Former name or former address, if changed since last report)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Class A common stock, $0.25 par value per share
GROW
NASDAQ Capital Market
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1934 (§240.12b-2 of this chapter)
 
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 

 
 
Item 4.02(a). Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review.
 
 
On May 29, 2026 the Audit Committee of the Board of Directors (the “Audit Committee”) of U.S. Global Investors, Inc. (the “Company”), in consultation with management, concluded that the Company’s previously issued consolidated financial statements as of and for the three and nine months ended March 31, 2026 included in the Company’s Quarterly Report on Form 10‑Q filed with the Securities and Exchange Commission (the “SEC”) on May 13, 2026 (the “Original Form 10‑Q”) should no longer be relied upon.
 
The conclusion was based on the identification of an error in the calculation of basic and diluted weighted‑average number of common shares outstanding used to compute basic and diluted earnings per share (“EPS”). Specifically, a formula omission within the supporting spreadsheet excluded a component of shares from the summation used to calculate weighted-average shares, which resulted in an understatement of basic and diluted weighted‑average shares of 702,484 shares for the three months ended March 31, 2026, and 230,743 shares for the nine months ended March 31, 2026. As a result, previously reported basic and diluted EPS were overstated by $0.02 for the three‑month period and $0.01 for the nine‑month period. The error affected EPS as presented on the face of the statement of operations and in the related earnings per share disclosures, as well as related per-share discussion in Management’s Discussion and Analysis. Any previously furnished reports, press releases, earnings releases, and investor presentations or other communications describing the Company’s consolidated financial statements as of and for the three and nine months ended March 31, 2026, should no longer be relied upon. The error did not impact the Company’s revenues, expenses, net income (loss), cash flows, financial position, or shares outstanding at period end.
 
The Company intends to file an amendment to the Original Form 10‑Q (a “Form 10‑Q/A”) to restate the affected financial statements and related disclosures for the quarter ended March 31, 2026.
 
Management has evaluated the effect of the error and restatement on the Company’s disclosure controls and procedures and internal control over financial reporting and has concluded that a material weakness existed in internal control over financial reporting as of March 31, 2026, related to a failure in the operation of a review control over the number of weighted average shares outstanding  calculation at a sufficient level of precision to detect a completeness error in the underlying workpaper. Management is implementing remedial measures, including enhanced review procedures and controls over spreadsheet completeness and formula integrity.
 
The Audit Committee has discussed the matters disclosed in this Form 8-K with Grant Thornton LLP, the Company’s independent registered public accounting firm.
 
Cautionary Note Regarding Forward-Looking Statements
 
This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the expected impact of the error and restatement; the timing, form, and scope of any amended or future SEC filings; the expected conclusions regarding disclosure controls and procedures and internal control over financial reporting; and the Company’s remediation plans. These forward-looking statements are based on current expectations and assumptions and are subject to risks and uncertainties, including the discovery of additional information during the preparation of the restated financial statements, as well as the risk factors described in the Company’s SEC filings. Actual results may differ materially from those indicated by these forward-looking statements. The Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date of this report, except as required by law.
 
Item 9.01 Financial Statements and Exhibits. 
 
(d) Exhibits
 
Exhibit 99.1 – Press Release issued by U.S. Global Investors, Inc. dated June 1, 2026, Announces Intent to Restate EPS for the March 31, 2026, Financial Statements; Underlying Financial Results Unchanged.
 
Exhibit 104 - Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
 

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 
 
 
U.S. Global Investors, Inc.
 
 
By: /s/Lisa Callicotte                                                
      Lisa Callicotte
      CFO
 
Dated:     June 1, 2026
 
 

 

Exhibit 99.1

 

 

Contact:

Holly Schoenfeldt

Director of Marketing and Public Relations         

210.308.1268

hschoenfeldt@usfunds.com

ex_970591img001.jpg

 

For Immediate Release

 

U.S. Global Investors Announces Intent to Restate EPS for the March 31, 2026, Financial Statements; Underlying Financial Results Unchanged

*********************************************************************************************

 

SAN ANTONIOJune 1, 2026—U.S. Global Investors, Inc. (NASDAQ: GROW) (the “Company”), a registered investment advisory firm with longstanding experience in global markets and specialized sectors, today announced that it will restate its earnings per share (EPS) figures for the three-month and nine-month periods ended March 31, 2026, as previously reported in the Company’s Quarterly Report on Form 10-Q for the third quarter of fiscal year 2026.

 

Nature of the Restatement

 

The Company identified a miscalculation of basic and diluted weighted average shares outstanding used to determine basic and diluted EPS. Within a supporting spreadsheet, a component of shares was inadvertently omitted from the calculation, resulting in understated basic and diluted weighted average common shares and overstated basic and diluted EPS for the three- and nine-month periods ended March 31, 2026.

 

The miscalculation had no impact on the Company’s reported net income, total revenues, operating income, cash position or any other line item in the consolidated financial statements. Only the weighted average number of shares outstanding and the resulting per-share figures are affected.

 

“The miscalculation was a clerical omission in a supporting schedule, not a change in the Company’s underlying performance,” said Frank Holmes, CEO and Chief Investment Officer of U.S. Global Investors. “Because our share count moves every month as a result of our active buyback program, the weighted average share calculation is inherently dynamic. We have identified the issue and are implementing enhancements to our review procedures so that the per-share presentation of our results accurately reflects that dynamic in every reporting period.”

 

For the three months ended March 31, 2026, weighted average shares were understated by 702,484 shares, resulting in an overstatement of basic and diluted EPS of $0.02. Corrected basic and diluted EPS is $0.21, with restated weighted average shares outstanding of 12,561,208 (basic) and 12,585,586 (diluted).

 

For the nine months ended March 31, 2026, weighted average shares were understated by 230,743 shares, resulting in an overstatement of basic and diluted EPS of $0.01. The corrected basic and diluted weighted average shares outstanding and the basic and diluted EPS will be reflected in the Company’s amended Form 10-Q/A.

 

Any previously furnished reports, press releases, earnings releases and investor presentations or other communications describing the Company’s consolidated financial statements as of and for the three and nine months ended March 31, 2026, should no longer be relied upon. The Company intends to file an amendment on Form 10-Q/A with the Securities and Exchange Commission (SEC) as promptly as practicable. Investors and shareholders are encouraged to review the amended filing once available. All other financial data previously disclosed in connection with the third quarter of fiscal year 2026 remains unchanged.

 

 

 

 

Returning Capital to Shareholders

 

The Company’s commitment to returning capital to shareholders through its two-pillar strategy of monthly dividends and ongoing share repurchase program is longstanding. Over the five-year period ended March 31, 2026, the Company repurchased approximately 2.7 million shares of its common stock, representing a more-than 20% reduction.

 

a01.jpg

 

“I want to assure our shareholders that the fundamentals of our business remain strong,” said Mr. Holmes. “Net income for the quarter ended March 31, 2026, was $2.7 million, and our average assets under management (AUM) reached $1.6 billion, the highest level in nearly two years. The correction to our per-share figures does not change the underlying story of a profitable quarter.”

 

About U.S. Global Investors, Inc.

 

The story of U.S. Global Investors goes back more than 50 years when it began as an investment club. Today, U.S. Global Investors, Inc. (www.usfunds.com) is a registered investment adviser that focuses on niche markets around the world. Headquartered in San Antonio, Texas, the Company provides investment management and other services to U.S. Global Investors Funds and U.S. Global ETFs.

 

To sign up for news and research on a variety of asset classes, from gold to airlines to digital assets, please click here.

 

Follow U.S. Global Investors on X by clicking here.

 

Subscribe to U.S. Global Investors YouTube channel by clicking here.

 

# # #

 

This news release may include certain “forward-looking statements” including statements relating to revenues, expenses, and expectations regarding market conditions. These statements involve certain risks and uncertainties. There can be no assurance that such statements will prove accurate and actual results and future events could differ materially from those anticipated in such statements.

 

Bloomberg data for the period May 13, 2026, through May 29, 2026, shows that GROW shares traded in a range of $2.55 to $2.71, with an average of $2.63 and a net change of just $0.09, or 3.53%. Average daily trading volume was 24,154.

 

 

FAQ

Why is U.S. Global Investors (GROW) restating its EPS for March 31, 2026?

U.S. Global Investors is restating EPS because a spreadsheet formula omitted a component of shares, understating weighted-average shares and overstating basic and diluted EPS by $0.02 for the quarter and $0.01 for the nine months. Only per-share figures are affected; core financials remain unchanged.

How does the EPS restatement affect U.S. Global Investors (GROW) financial results?

The restatement adjusts only EPS and weighted-average shares. Revenues, expenses, net income, cash flows, financial position, and period-end share counts are unchanged. For the quarter, corrected basic and diluted EPS is $0.21, based on updated weighted-average share figures disclosed by the company.

What material weakness did U.S. Global Investors (GROW) disclose in its controls?

Management identified a material weakness in internal control over financial reporting related to review of the weighted-average shares outstanding calculation. The control did not operate at a sufficient level of precision to detect the spreadsheet completeness error, prompting remediation steps to strengthen review procedures and spreadsheet integrity checks.

What operating metrics did U.S. Global Investors (GROW) report for the March 31, 2026 quarter?

Net income for the quarter ended March 31, 2026 was $2.7 million, and average assets under management were $1.6 billion, the highest level in nearly two years. These figures are unaffected by the EPS restatement and are presented as evidence of a profitable quarter for the firm.

How active has U.S. Global Investors (GROW) been in repurchasing its stock?

Over the five-year period ended March 31, 2026, the company repurchased approximately 2.7 million shares of its common stock. Management states this represents a reduction of more than 20% in shares, reflecting a longstanding capital return strategy alongside monthly dividends.

How did GROW shares trade around the EPS restatement timeframe?

Bloomberg data cited by the company show GROW shares traded between $2.55 and $2.71 from May 13, 2026 through May 29, 2026, with an average price of $2.63. Over that span, the net price change was $0.09, or 3.53%, on average daily volume of 24,154 shares.

Filing Exhibits & Attachments

5 documents